Do Dual-Action Neurotransmitter Agents Offer an Advantage in Psychiatric Treatment?

Richard C. Shelton, Dennis S. Charney, Madhukar Trivedi, David L. Ginsberg

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Do Dual-Action Neurotransmitter Agents Offer an Advantage in Psychiatric Treatment?'. Together they form a unique fingerprint.

Medicine & Life Sciences